Assessment of cardiac hemodynamics indicators in patients with arterial hypertension and non-alcoholic fatty liver disease depending on angiotensin II type 1 receptor A1166C gene polymorphism
DOI:
https://doi.org/10.14739/2310-1210.2018.3.130462Keywords:
hemodynamics, hypertension, non-alcoholic fatty liver disease, genetic polymorphism, angiotensin IIAbstract
Aim of study is to estimate the indicators of cardiac hemodynamics in patients with arterial hypertension and non-alcoholic fatty liver disease depending on angiotensin II type 1 receptor (A1166C) gene polymorphism.
Materials and methods. 55 patients with arterial hypertension and non-alcoholic fatty liver disease were comprehensively examined. The study of angiotensin II type 1 receptor (A1166C) gene polymorphism was carried out by means of the polymerase chain reaction method. Accuracy of genotype frequency distribution was assessed in accordance with the Hardy-Weinberg Equilibrium (pi2 + 2 pipj + pj2 = 1).
Results. In the subgroup of patients with arterial hypertension and non-alcoholic fatty liver disease with the angiotensin II type 1 receptor gene (A1166C) C/C genotype the values of end-diastolic volume exceeded by 13.45 % and 28.31 %; the end-systolic volume –by 22.41 % and 39.09 %; the end-diastolic diameter – by 10.67 % and 38.95 %; the end systolic diameter – by 15.63 % and 29.11 %; the left ventricular mass – by 11.18 % and 19.38 %, whereas the ejection fraction was lower compared to patients with the A/C and A/A genotypes, respectively (p<0.05). According to our study results, no differences in left ventricular diastolic dysfunction were found depending on angiotensin II type 1 receptor (A1166C) gene polymorphism in the examined patients.
Conclusions. The C allele of angiotensin II type 1 receptor (A1166C) gene polymorphism in patients with arterial hypertension and non-alcoholic fatty liver disease is associated with the heart morphofunctional changes, namely, hypertrophy progression, left ventricular cavity size and volume enlargement and decrease in myocardial contractility.
References
Kozlov, O. P. (2012). Stan vnutrishniosertsevoi hemodynamiky u khvorykh na nealkoholnu zhyrovu khvorobu pechinky [Condition of intracardiac hemodynamics in patients with non-alcoholic fatty liver disease]. Odeskyi medychnyi zhurnal, 4(132), 42–47. [in Ukrainian].
Devi, N., Lakshmi, V., Padhy, K., Padhy, R., & Veerraju, P. (2013). Angiotensin converting enzyme gene polymorphism and hypertension in north coastal Andhra Pradesh, India. International J. of medical and health sciences, 2(1), 1–12.
Wang, J. L., Li, X., Hao, P. P., Feng, X., Chen, Y. G., & Yun, Z. (2010). Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysis. J. Renin Angiotensin Aldosterone Syst, 11, 127–135. doi: 10.1177 / 1470320310364181.
Kato, N., Tatara, Y., Ohishi, M., Takeya, Y., Onishi, M., Maekawa, Y., & Rakugi, H. (2011). Angiotensin-converting enzyme single nucleotide polymorphism is a genetic risk factor for cardiovascular disease: a cohort study of hypertensive patients. Hypertension Research, 34(6), 728–734. doi: 10.1038/hr.2011.28.
Ramu, P., Umamaheswaran, G., Shewade, D. G., Swaminathan, R. P., Dutta, T. K., Balachander, J., & Adithan, C. (2011). Candidate gene polymorphisms of renin angiotensin system and essential hypertension in a South Indian Tamilian population. International J. of Human Genetics, 11(1), 31–40. doi: 10.1080/09723757.2011.11886120.
Alqahtani, S. A., Fouad, T. R., & Lee, S. S. (2008). Cirrhotic cardiomyopathy. Semin Liver Dis, 28, 59–69. doi: 10.1055 / s-2008-1040321.
Franchuk, S. V. (2012). Sex features of the development left ventricular myocardial hypertrophy in patients with essential hypertension which suffered from vascular complication when inherit of different variants of angiotensin II type 1 receptor gene. Visnyk Vinnitskogo natsionalnogo medychnogo universitetu, 2(16), 446–452.
Benetos, A., Giron, A., Joly, L., Temmar, M., Nzietchueng, R., Pannier, B., et al. (2013). Influence of the AGTR1 A1166C Genotype on the Progression of Arterial Stiffness: A 16-Year Longitudinal Study. Am. J. Hypertens, 26, 1421–1427. doi: 10.1093/ajh/hpt141.
Mehri, S., Mahjoub, S., Hammami, S., Zaroui, A., Frih, A., Betbout, F., et al. (2012). Renin-angiotensin system polymorphisms in relation to hypertension status and obesity in a Tunisian population. Molecular Biology Reports, 39(4), 4059–4065. doi: 10.1007/s11033-011-1187-2.
Sugawara, A., Takeuchi, K., Uruno, A., Ikeda, Y., Arima, S., Kudo, M., et al. (2001). Transcriptional Suppression of Type 1 Angiotensin II Receptor Gene Expression by Peroxisome Proliferator-Activated Receptor-in Vascular Smooth Muscle Cells. Endocrinology, 142(7), 3125–3134. doi: 10.1210/endo.142.7.8272.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
